Zobrazeno 1 - 10
of 90
pro vyhledávání: '"A A Cheldieva"'
Autor:
T. M. Reshetnyak, F. A. Cheldieva, N. M. Kosheleva, A. A. Shumilova, L. M. Blank, N. V. Seredavkina
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 325-330 (2024)
Obstetric pathology (pregnancy loss at different gestational ages; premature delivery of morphologically normal foetus due to pre-/eclampsia or placental insufficiency), along with thrombotic complications are the main clinical manifestations of anti
Externí odkaz:
https://doaj.org/article/fb3c934fe22043f8bd437d4f4bf1222d
Autor:
Tatiana M. Reshetnyak, Fariza A. Cheldieva, Svetlana I. Glukhova, Kamila S. Nurbaeva, Nataliya V. Seredavkina, Mariya V. Cherkasova, Alexander M. Lila, Evgeny L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 4 (2024)
Thrombotic antiphospholipid syndrome (APS) is a condition affecting young people in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL).The aim of this study was the evaluation of the incidence of recur
Externí odkaz:
https://doaj.org/article/1428993700ed44f597b48a871e1f56c7
Autor:
А. В. Borisova, Т. А. Lisitsyna, D. Yu. Veltishchev, Т. М. Reshetnyak, О. F. Seravina, О. В. Kovalevskaya, F. А. Cheldieva, А. А. Abramkin, А. Е. Zeltyn, Е. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 176-185 (2024)
The aim of this work is to clarify the association between the clinical and psychopathological features of mental disorders (MD) and the clinical and immunological features of antiphospholipid syndrome (APS).Material and methods. The study included 1
Externí odkaz:
https://doaj.org/article/4173f45fcc584995bb91045ad8b12d07
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 203-215 (2024)
Introduction. Cutaneous Lupus Disease Area and Severity Index (CLASI) and its modified version, the Revised Cutaneous Lupus Erythematosus Disease Areas and Severity Index (R-CLASI) are tools for quantifying skin and mucosal lesions in patients with b
Externí odkaz:
https://doaj.org/article/6db9f0bd62984e4c935d754b4191c688
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 15-21 (2023)
To date, the management of patients with antiphospholipid syndrome (APS) with ineffectiveness and/or intolerance to vitamin K antagonists and direct oral anticoagulants remains controversial. One of the treatment strategies is the administration of l
Externí odkaz:
https://doaj.org/article/09e4ca76caef4b979b8a329aa5f453d5
Autor:
A. A. Shumilova, F. A. Cheldieva, K. S. Nurbaeva, T. A. Lisitsyna, L. M. Carter, E. M. Vital, T. M. Reshetnyak
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 107-111 (2023)
Assessment of systemic lupus erythematosus (SLE) activity is important to determine the efficacy of treatment and to decide on further therapy. Russian-language versions of activity indices are needed to meet the needs of Russian-speaking patients an
Externí odkaz:
https://doaj.org/article/2546513de6c54675b0cb8b477063728e
Autor:
Fariza A. Cheldieva, Anastasiia A. Shumilova, Mariya V. Cherkasova, Svetlana I. Glukhova, Aleksander M. Lila, Evgeny L. Nasonov, Tatiana M. Reshetnyak
Publikováno v:
Exploration of Immunology, Vol 3, Iss 5, Pp 475-489 (2023)
Aim: The study aims to evaluate the incidence of recurrent thromboses in patients with primary antiphospholipid syndrome (PAPS) and its association with the presence of different antiphospholipid antibodies (aPLs) and known thrombogenic risk factors.
Externí odkaz:
https://doaj.org/article/deca439db8e0417dbb2ad480b606a20b
Autor:
Tatiana M. Reshetnyak, Tatiana A. Lisitsyna, Fariza A. Cheldieva, Anastasiia A. Shumilova, Svetlana I. Glukhova, Mayya N. Starovoytova, Nataliya V. Seredavkina, Oxana V. Desinova, Zhanna G. Verizhnikova, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 95, Iss 5, Pp 410-417 (2023)
Background. The clinical and serologic heterogeneity of systemic lupus erythematosus (SLE) presents challenges for diagnosis, particularly in the earliest stages of the disease when there are insufficient signs to make a reliable diagnosis. Aim. T
Externí odkaz:
https://doaj.org/article/9808fe316e40451bb70011d39d0fe7c8
Autor:
F. A. Cheldieva, T. M. Reshetnyak, A. A. Shumilova, K. S. Nurbaeva, M. V. Cherkasova, A. M. Lila, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 5, Pp 546-553 (2022)
Introduction. The Global Antiphospholipid Syndrome Score (GAPSS) is a tool proposed to quantify the risk of clinical manifestations associated with antiphospholipid antibodies (aPL) and certain cardiovascular risk factors.Objective. To validate GAPSS
Externí odkaz:
https://doaj.org/article/34f8ead4e6d14878ab149c2a524fc281
Autor:
Tatiana Reshetnyak, Fariza Cheldieva, Anastasia Borisova, Olga Seravina, Oksana Kovalevskaya, Yuriy Veltishchev, Tatyana Lisitsyna, Anton Abramkin, Artur Zeltyn
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e66f33a859df4bfc82d5fe9dd155a465